Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg
Clinical trial NCT00649376 · COMPLETED
Trial details
- NCT number
- NCT00649376
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2003-11-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.